PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Precision medicine is an innovative approach that tailors treatment to the unique genetic and molecular characteristics of a ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations ... the most common type of lung cancer.

Sabari, MD, which focused on the first-line approval of amivantamab (Ami; Rybrevant; Johnson & Johnson) plus lazertinib ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological disea ...

When Sue Vincent was diagnosed with advanced ovarian cancer, she was told she could have just months to live - until a miracle drug changed everything ...

The food you eat may be affecting your body's ability to fight cancer cells in the colon, according to a new study.

BeiGene (BGNE) announced it has entered into a global licensing agreement with CSPC Zhongqi Pharmaceutical Technology Co., Ltd. for SYH2039, a ...

Since the launch of the region’s first Personalised Precision Medicine Programme for Oncology in October 2022, the Department ...

The FDA's so-called complete response letter was related to observations as part of a standard pre-approval inspection at a ...